• Research
    • Our Mission
    • Multidrug Therapies
    • Surveillance
    • Stewardship
    • Education & Outreach
    • Publications
  • Resources & Services
    • Drug Combinations Lab
    • Levy CIMAR Summer Internship
    • AMR Pre-College Program
    • Educational Resources
    • For Levy CIMAR Faculty
    • Our Values
  • Publications
  • People
    • Leadership
    • Core Faculty
    • Affiliate Members
    • Featured Trainees
    • About Stuart B. Levy, M.D. 
  • News
    • Upcoming Events
    • Levy CIMAR in the News
    • Press Releases
  • Giving
  • Contact

An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic Yersinia

by Levy CIMAR | Nov 1, 2018 | Publications

The PARE Project: A Short Course-Based Research Project for National Surveillance of Antibiotic-Resistant Microbes in Environmental Samples

by Levy CIMAR | Oct 31, 2018 | Publications

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection

by Levy CIMAR | Oct 12, 2018 | Publications

The landscape of intrinsic and evolved fluoroquinolone resistance in Acinetobacter baumannii includes suppression of drug-induced prophage replication

by Levy CIMAR | Oct 1, 2018 | Publications

Microbial Identification Using DNA Target Amplification and Sequencing: Clinical Utility and Impact on Patient Management

by Levy CIMAR | Oct 1, 2018 | Publications

Page 79 of 86« First«...102030...7778798081...»Last »

Recent Posts

  • EXPRESS: Factors associated with antimicrobial drug prescription in cats receiving outpatient care at a veterinary teaching hospital
  • Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps
  • Growth arrest of Mycobacterium tuberculosis in acidic environments enhances their survival of antibiotic treatment
  • Point-Counterpoint: The “obsoletogram”—are annual hospital antibiograms still relevant?
  • Species-level reporting of Coagulase-negative staphylococci with MALDI-TOF does not impact clinical outcomes

The Levy CIMAR is a collaboration of Tufts Medical Center and the Tufts University Office of the Vice Provost for Research (OVPR) Research and Scholarship Strategic Plan (RSSP).

Contact us



South Cove 502, 136 Harrison Ave. Boston, MA. 02111



(617) 636-3824



CIMAR@tufts.edu

Join the CIMAR mailing list

Stay updated with our latest research, events and news.

© 2026 LevyCIMAR. All Rights Reserved.